Illumina (ILMN) logo

Illumina (ILMN) stock

Genetic sequencing tools , market cap $31B

$213.13
+2.47%

As of Friday's close · Live for Pro members at the open

Why ILMN fell 27% since Oct 29

Down 27% from Oct 29 to Nov 6 while the S&P 500 fell 4%.

“Illumina Crashes As Tariffs, AI Woes Eat Into 157% Run-Up.”

Oct 30: Investor's Business Daily reported

Sources: Price history, Nov 6, 2026; Investor's Business Daily, Oct 30, 2026

Tell me next time ILMN moves

Free account, no card. An optional alert when ILMN moves or its score changes.

Or see it live, free until Tuesday morning. No account.
1 more reason, free with an account →The other side, the timeline, and its peers, for Pro members.
Quality Score
9
Average
In its industry
#6of 15

ILMN's Quality Score was unchanged on Fri, Nov 6, at 9.

See ILMN's 14 chart checksSee it live, free until Tuesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on ILMN

Key facts on ILMN
Since its 2022 highDown 51% while profit grew 8%
Latest filing8-K, Oct 29 Reported its quarterly results
1 more reason behind ILMN's 9, free with an account →5 more reasons behind ILMN's 9, for Pro members.

ILMN in the news

Fri Oct 30Illumina reported quarterly revenue of $1.13 billion and diluted EPS of $1.43 SEC, 4:07 PM ET ILMN closed −18.6% that day.

What's next

Tue Nov 10: UBS Global Healthcare Conference 2026Investor conference · date confirmed.

1 more date ahead: the conference, for Pro members.

ILMN catalysts

Coming up

After its last 4 reports it closed -5.5% on average, higher 1 of 4 times.

42 past catalysts since 2018, with sizes and sources, for Pro members.Get in free →

Why ILMN scores 9

Averagefor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means

  • +2Long-term trend above a rising 200-⁠day average
  • +3News guidance raised, earnings beat, earnings miss
  • Chart checks adds
  • Run-up adds
  • Size adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Persistence adds
  • Insider trades subtracts

No effect today: Growth, Dilution, Volatility, and Cash flow.

What every line is worth, and the reason behind it, on ILMN and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 12:19 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on ILMN and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

ILMN has 1 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on ILMN, and all 14 on every stock.Get in free →

ILMN RSI on Nov 6: 35.5, below its 50-day, above its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

The deep dive on ILMN

  • What it does and how it makes money5 findingsServices made up 15% of its revenue in fiscal 2025 ($634M of $4.34B), against 16% in fiscal 2024; product sales 85%.SEC filing · Feb 12, 2026"As of December 28, 2025, we owned or had exclusive licenses to 1,380 issued U.S. patents and 1,120 pending U.S. patent applications and 7,653 issued patents outside the U.S. and 4,218 pending patent applications outside the U.S. Our issued and pending patents cover various aspects of our arrays, assays …" (10-K for fiscal 2025)SEC filing · Feb 12, 2026
  • Where it stands4 findingsFor Pro members4 findings on where ILMN stands: its cash, debt, and share count, for Pro members
  • What changed in its filings4 findings"On July 28, 2026, the Company filed a writ with the California Court of Appeals seeking interlocutory appellate review of the court’s order granting class certification." (10-Q for the quarter to Jun 28, 2026)SEC filing · Jul 31, 2026Backlog rose 16% in a year, to $1.00B on Jun 28, 2026 from $862M: sales under contract, not yet delivered.Filed figures, Jun 28, 2026
  • Who holds and trades it4 findingsFor Pro members4 findings on who holds and trades ILMN, for Pro members
  • Against its closest peers4 peersShare count against a year before: ILMN -3.8%, WAT +65%, TXG +5%, A -0.7%.
13 more findings on ILMN, each with its source, for Pro membersGet in free →

How ILMN ranks in Life Science Tools

ILMN is #6 of 15 by Quality Score among Laboratory Analytical Instruments.

How ILMN ranks in Life Science Tools
6Illumina (ILMN) logoILMNIllumina9

Share count against a year before: ILMN -3.8%, WAT +65%, TXG +5%, A -0.7%.

More in Life Science Tools

When does ILMN report earnings, and what happens after?

Expected to report Thu Feb 4, after the close (in 89 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What ILMN reported on Oct 29, 2026

The quarter

Sales of $1.1B, 4% more than a year ago; a profit of $1.43 a share, from $0.98.

The quarter that ended Sep 27, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

ILMN's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
MeasureFigure
Fiscal year 2026
Total revenue$4.64B to $4.66Braised

Figures as filed (SEC filing, Oct 29)

4 more outlook lines, for Pro members.

The numbers

Market value
$31B
today
Sales
$4.5B
up 4.9% on the year
Free cash flow
$931M
last 12 months

Sales grew 6% a year over 5 years, fiscal 2020 to 2025.

Its share count grew 1.1% a year over 5 years.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on ILMN: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →
ReportedGapReaction5
sessions
Oct 29, 2026After close-11.8%-18.6%-28.3%
Jul 30, 2026After close-0.9%0.0%-5.5%
Apr 30, 2026After close+5.1%+7.1%+9.4%

ILMN closed higher after 1 of its last 4 reports.

All 4 reports, and ILMN's Quality Score going into each

ILMN sales and profit by year

Sales and profit by year

Sales grew in three of the last seven years, to $4.3B in 2025. It turned a profit in 2025 after a loss in 2024.

Insiders trading ILMN

ILMN insider trades

One insider sold $658M across 106 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellKeith A. Meister$25.5MDirectorat $238.49 on Nov 3, filed Nov 5
The newest 100 of ILMN's 106 insider filings from the last six months, for Pro members.Get in free →

All ILMN insider trades

ILMN trades by Congress and the executive branch

2 trades disclosed in the last six months. The newest:

BuyDonald Trump$1K to $15KPresident (R)traded Apr 15, disclosed Jul 1(77 days later)
All 2 trades on ILMN disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

ILMN's officers and directors

Officers and directors with a Form 4 in the last 12 months.

11 more officers and directors file at ILMN. Each page above names the rest.

See insider trades by person

Which ETFs hold ILMN?

In ETFs: ILMN is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Illumina

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

8,650 employeesSan Diego, CAillumina.com

ILMN's score card

Illumina (ILMN): Quality Score 9, Average, #6 of 15 in Life Science Tools, with its price, on Breakaway
The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

  • What would move ILMN's score: 6 things
  • 3 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayJul 1Donald Trump bought ILMN$1K to $15K, disclosed Jul 1

Alerts are optional.

See ILMN's 14 chart checks

See it live, free until Tuesday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 7, 2026: ILMN's Quality Score is 9 (Average), #6 of 15 in Laboratory Analytical Instruments. Insiders sold $658M in the last 6 months (Form 4).

Is ILMN a good stock to buy? What its Quality Score says

ILMN scores 9 today, which Breakaway calls Average. It is #6 of 15 in Laboratory Analytical Instruments by Quality Score, with 1 of 14 chart checks firing. Down 27% from Oct 29 to Nov 6 while the S&P 500 fell 4%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is ILMN's Quality Score?

ILMN scores 9 today, which Breakaway calls Average (6 to 10). That is #6 of 15 in Laboratory Analytical Instruments by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ILMN's 9.

Are insiders buying ILMN?

One insider sold $658M across 106 filings in the last 6 months. No open-⁠market buys on record. The newest is Keith A. Meister, Director, who sold $25.5M on Nov 3. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.